• CONTACT
  • 中文
  • HOME
  • SCIENCE
  • PIPELINE
  • TEAM
  • NEWS
    • PRESS RELEASE
    • PUBLICATION
    • COLLABORATION
  • CAREER

AACR 2021 Posters

April, 2021
Discovery of ETS-001, a Highly Potent Allosteric SHP2 Inhibitor to Treat RTK/RAS-driven Cancers

April, 2021
Structural dynamics-based hit generation to disrupt YAP-TEAD protein-protein interaction

September 30, 2020
Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation
© 2021 ETERN BioPharma. All Rights Reserved.
    • CONTACT
    • 中文